Developer docs
API playgroundTry for free, no card

Search company profiles

qGenomics

Full company profile

uuid000fubc

Namestring
qGenomics
Websiteurl
qgenomics.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

qGenomics was a private biotechnology company headquartered in Barcelona, Spain, founded in 2008, that operated in the clinical genomics diagnostics vertical within the European market. The company built and maintained a focused product portfolio consisting of two offerings: the qMatching Platform (V.3), a web-accessible genomics matching platform enabling researchers and clinical professionals to match, compare, and analyze genomic data; and qIntranet, an internal management and operations platform providing authenticated access to organizational resources and workflows for staff and authorized users. Its value proposition centered on specialized genomics diagnostics capabilities for clinical applications, with domain specialization and ease of implementation cited as the primary technical differentiators.

The company operated with a small team of 11-50 employees and pursued a vertical segmentation approach targeting clinical and research genomics users. No pricing model, revenue mechanics, go-to-motion, named customers, or funding history is publicly documented in available sources, leaving the commercial structure of the business substantially opaque. On September 17, 2025, qGenomics was acquired by Veritas Genetics for an undisclosed amount, with the stated strategic intent of expanding Veritas's capabilities in genomics diagnostics and its European clinical market presence. Following the acquisition, qGenomics ceased operating as an independent entity, its primary website was replaced with a redirect notice, and its services, including the qMatching Platform and qIntranet, were integrated into and made available through Veritas Genetics' platform and infrastructure.

Short descriptiontext

qGenomics is a Barcelona-based biotech that built genomics diagnostics tools, notably the qMatching Platform and qIntranet, for clinical and research users in Europe before being acquired by Veritas Genetics in September 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomics diagnostics services, clinical genomic analysis, genomic data matching, biotech health diagnostics, clinical genomics platform
Industry4 codes
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Genomics Software
Social media profiles3 records
Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

qGenomics provided genomics diagnostics services through its flagship qMatching Platform (V.3), enabling researchers and clinical professionals to match, compare, and analyze genomic data for clinical applications. It also offered the qIntranet tool for internal management and authenticated access to organizational resources. Following its acquisition by Veritas Genetics on September 17, 2025, these services were integrated into and made available through Veritas Genetics' platform.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

qGenomics offered a focused product portfolio consisting of two main offerings: the qMatching Platform (V.3), a genomics matching platform for analyzing and comparing genomic data, and qIntranet, an internal management tool for organizational access control. Following its acquisition by Veritas Genetics in September 2025, these services are now integrated into and available through Veritas Genetics' platform. The company operated as a unified product offering with the qMatching Platform serving as the primary public-facing product and qIntranet serving internal operational needs.

Product and service1 record
1qMatching Platform (V.3)
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-17
Description

Veritas Genetics acquired qGenomics on September 17, 2025, for an undisclosed amount. The acquisition was strategic, aimed at expanding Veritas Genetics' capabilities in genomics diagnostics with focus on clinical applications and European market presence. Following the acquisition, qGenomics services are now integrated into and available through Veritas Genetics' platform and website.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Genomics data and analytics platform with European presence, offering tools for genomic data management, matching, and clinical interpretation. Comparable both in capability and in regional focus.

TypeBroad incumbent
Description

European-headquartered clinical genomics analytics platform used by hospitals for matching and analyzing genomic data — broadly comparable to qMatching's clinical genomics matching/analysis purpose.

TypeEmerging player
Description

Clinical genomics analytics company providing matching and analysis workflows for precision oncology; comparable as a niche analytics operator adjacent to qGenomics' matching platform.

TypeDirect peer
Description

Provides a cloud-based genomics data management and analysis platform used by clinical and research customers. Directly comparable to qMatching as a genomic data matching/analysis infrastructure layer for clinical applications.

TypeBroad incumbent
Description

Large, established clinical genomics profiling and matching service for oncology — broader portfolio than qGenomics but analogous clinical-genomics matching/interpretation workflow.

TypeDirect peer
Description

Clinical genomics interpretation platform used by hospitals and labs for variant analysis and matching in clinical workflows. Closely comparable clinical-genomics analysis offering to qMatching.

TypeBroad incumbent
Description

Dominant sequencer and genomics-infrastructure vendor whose BaseSpace and connected analytic ecosystems encompass matching/analysis functions overlapping with qMatching's domain.

TypeBroad incumbent
Description

European-headquartered clinical genomics lab and diagnostic service provider focused on rare and hereditary disease testing, operating in a directly adjacent niche to qGenomics' clinical genomics focus.

TypeDirect peer
Description

AI-driven clinical genomics interpretation platform for variant matching and clinical reporting — directly overlaps with qMatching's clinical genomics matching and analysis positioning.

TypeDirect peer
Description

The acquirer of qGenomics and now its parent; Veritas Genetics is a clinical genomics company offering whole-genome sequencing and related diagnostic services, making it the most directly comparable operator given shared clinical-genomics focus.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

qGenomics

Clinical Genomics Softwareqgenomics.com

qGenomics is a Barcelona-based biotech that built genomics diagnostics tools, notably the qMatching Platform and qIntranet, for clinical and research users in Europe before being acquired by Veritas Genetics in September 2025.

What qGenomics does

qGenomics was a private biotechnology company headquartered in Barcelona, Spain, founded in 2008, that operated in the clinical genomics diagnostics vertical within the European market. The company built and maintained a focused product portfolio consisting of two offerings: the qMatching Platform (V.3), a web-accessible genomics matching platform enabling researchers and clinical professionals to match, compare, and analyze genomic data; and qIntranet, an internal management and operations platform providing authenticated access to organizational resources and workflows for staff and authorized users. Its value proposition centered on specialized genomics diagnostics capabilities for clinical applications, with domain specialization and ease of implementation cited as the primary technical differentiators.

The company operated with a small team of 11-50 employees and pursued a vertical segmentation approach targeting clinical and research genomics users. No pricing model, revenue mechanics, go-to-motion, named customers, or funding history is publicly documented in available sources, leaving the commercial structure of the business substantially opaque. On September 17, 2025, qGenomics was acquired by Veritas Genetics for an undisclosed amount, with the stated strategic intent of expanding Veritas's capabilities in genomics diagnostics and its European clinical market presence. Following the acquisition, qGenomics ceased operating as an independent entity, its primary website was replaced with a redirect notice, and its services, including the qMatching Platform and qIntranet, were integrated into and made available through Veritas Genetics' platform and infrastructure.

qGenomics firmographics

Firmographics
Name
qGenomics
Website
https://qgenomics.com
Company type
Private
Founded year
2008
Operating status
Acquired
Headcount range
11–50 employees
Short description
qGenomics is a Barcelona-based biotech that built genomics diagnostics tools, notably the qMatching Platform and qIntranet, for clinical and research users in Europe before being acquired by Veritas Genetics in September 2025.
Ownership category
akta.pro rank

qGenomics industry classification

Industry
Product category
Clinical Genomics Software
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Genomics diagnostics services
  • Clinical genomic analysis
  • Genomic data matching
  • Biotech health diagnostics
  • Clinical genomics platform

Where qGenomics is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

qGenomics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

qGenomics product offering

Product offering

Core offering

qGenomics provided genomics diagnostics services through its flagship qMatching Platform (V.3), enabling researchers and clinical professionals to match, compare, and analyze genomic data for clinical applications. It also offered the qIntranet tool for internal management and authenticated access to organizational resources. Following its acquisition by Veritas Genetics on September 17, 2025, these services were integrated into and made available through Veritas Genetics' platform.

Product overview

qGenomics offered a focused product portfolio consisting of two main offerings: the qMatching Platform (V.3), a genomics matching platform for analyzing and comparing genomic data, and qIntranet, an internal management tool for organizational access control. Following its acquisition by Veritas Genetics in September 2025, these services are now integrated into and available through Veritas Genetics' platform. The company operated as a unified product offering with the qMatching Platform serving as the primary public-facing product and qIntranet serving internal operational needs.

Differentiator

Problem solved

Functional benefit

Products and services

  • qMatching Platform (V.3)

Companies that use qGenomics

Customer profile

Ideal customer profiles1 record

qGenomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

qGenomics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Veritas GeneticscoreStrategic or Co-development Partner · 17 September 2025Veritas Genetics acquired qGenomics on September 17, 2025, for an undisclosed amount. The acquisition was strategic, aimed at expanding Veritas Genetics' capabilities in genomics diagnostics with focus on clinical applications and European market presence. Following the acquisition, qGenomics services are now integrated into and available through Veritas Genetics' platform and website.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

qGenomics competitors and assessment

Company assessment

Direct peers

  • BC Platforms: Genomics data and analytics platform with European presence, offering tools for genomic data management, matching, and clinical interpretation. Comparable both in capability and in regional focus.
  • DNAnexus: Provides a cloud-based genomics data management and analysis platform used by clinical and research customers. Directly comparable to qMatching as a genomic data matching/analysis infrastructure layer for clinical applications.
  • Congenica: Clinical genomics interpretation platform used by hospitals and labs for variant analysis and matching in clinical workflows. Closely comparable clinical-genomics analysis offering to qMatching.
  • Fabric Genomics: AI-driven clinical genomics interpretation platform for variant matching and clinical reporting — directly overlaps with qMatching's clinical genomics matching and analysis positioning.
  • Veritas Genetics: The acquirer of qGenomics and now its parent; Veritas Genetics is a clinical genomics company offering whole-genome sequencing and related diagnostic services, making it the most directly comparable operator given shared clinical-genomics focus.

Broad incumbents

  • SOPHiA Genetics: European-headquartered clinical genomics analytics platform used by hospitals for matching and analyzing genomic data — broadly comparable to qMatching's clinical genomics matching/analysis purpose.
  • Foundation Medicine: Large, established clinical genomics profiling and matching service for oncology — broader portfolio than qGenomics but analogous clinical-genomics matching/interpretation workflow.
  • Illumina: Dominant sequencer and genomics-infrastructure vendor whose BaseSpace and connected analytic ecosystems encompass matching/analysis functions overlapping with qMatching's domain.
  • Centogene: European-headquartered clinical genomics lab and diagnostic service provider focused on rare and hereditary disease testing, operating in a directly adjacent niche to qGenomics' clinical genomics focus.

Emerging players

  • GenomOncology: Clinical genomics analytics company providing matching and analysis workflows for precision oncology; comparable as a niche analytics operator adjacent to qGenomics' matching platform.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

qGenomics social profiles

Digital presence

qGenomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

qGenomics leadership team

Management profile

Number of profiles

qGenomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

qGenomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about qGenomics

What does qGenomics do?

qGenomics provided genomics diagnostics services through its flagship qMatching Platform (V.3), enabling researchers and clinical professionals to match, compare, and analyze genomic data for clinical applications. It also offered the qIntranet tool for internal management and authenticated access to organizational resources. Following its acquisition by Veritas Genetics on September 17, 2025, these services were integrated into and made available through Veritas Genetics' platform.

Is qGenomics a public or private company?

qGenomics is a private company. It is classified as corporate owned and is currently acquired.

When was qGenomics founded?

qGenomics was founded in 2008. It employs 11 to 50 people.

Where is qGenomics based?

qGenomics is headquartered in Barcelona, Spain, in the Europe region.

Who are qGenomics's main competitors?

Direct peers on record are BC Platforms, DNAnexus, Congenica, Fabric Genomics and Veritas Genetics. Broad incumbents are SOPHiA Genetics, Foundation Medicine, Illumina and Centogene. GenomOncology is listed as an emerging player.

Does qGenomics have an API?

No public API is recorded for qGenomics.

What industry is qGenomics in?

qGenomics's product category is Clinical Genomics Software. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals